News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,164 Results
Type
Article (46736)
Company Profile (297)
Press Release (669131)
Section
Business (209251)
Career Advice (2210)
Deals (36029)
Drug Delivery (112)
Drug Development (82309)
Employer Resources (188)
FDA (16333)
Job Trends (15233)
News (352582)
Policy (33213)
Tag
Academia (2730)
Alliances (50916)
Alzheimer's disease (1359)
Approvals (16313)
Artificial intelligence (229)
Bankruptcy (363)
Best Places to Work (11835)
Biotechnology (203)
Breast cancer (233)
Cancer (1795)
Cardiovascular disease (137)
Career advice (1848)
CAR-T (138)
Cell therapy (387)
Clinical research (66095)
Collaboration (708)
Compensation (380)
COVID-19 (2650)
C-suite (176)
Data (1694)
Diabetes (222)
Diagnostics (6453)
Earnings (86527)
Employer resources (160)
Events (114663)
Executive appointments (598)
FDA (17278)
Funding (639)
Gene therapy (268)
GLP-1 (706)
Government (4516)
Healthcare (19187)
Infectious disease (2769)
Inflammatory bowel disease (129)
Interviews (351)
IPO (16687)
Job creations (3840)
Job search strategy (1585)
Layoffs (461)
Legal (8053)
Lung cancer (265)
Manufacturing (251)
Medical device (13431)
Medtech (13436)
Mergers & acquisitions (19728)
Metabolic disorders (591)
Neuroscience (1791)
NextGen: Class of 2025 (6722)
Non-profit (4651)
Northern California (2187)
Obesity (330)
Opinion (215)
Patents (176)
People (58907)
Phase I (20584)
Phase II (29106)
Phase III (21673)
Pipeline (776)
Postmarket research (2642)
Preclinical (8913)
Radiopharmaceuticals (249)
Rare diseases (334)
Real estate (6220)
Regulatory (22420)
Research institute (2472)
Resumes & cover letters (376)
Southern California (1876)
Startups (3778)
United States (19412)
Vaccines (645)
Weight loss (232)
Date
Today (19)
Last 7 days (818)
Last 30 days (2651)
Last 365 days (34927)
2025 (5357)
2024 (35962)
2023 (40874)
2022 (51944)
2021 (56525)
2020 (54924)
2019 (47700)
2018 (35970)
2017 (33118)
2016 (32693)
2015 (38795)
2014 (32402)
2013 (27579)
2012 (29834)
2011 (30561)
2010 (29073)
Location
Africa (797)
Arizona (220)
Asia (39294)
Australia (6473)
California (5000)
Canada (1751)
China (417)
Colorado (233)
Connecticut (235)
Europe (85260)
Florida (732)
Georgia (180)
Illinois (478)
Indiana (276)
Maryland (772)
Massachusetts (3817)
Michigan (216)
Minnesota (358)
New Jersey (1416)
New York (1436)
North Carolina (890)
Northern California (2187)
Ohio (176)
Pennsylvania (1135)
South America (1172)
Southern California (1876)
Texas (735)
Utah (155)
Washington State (481)
716,164 Results for "sight sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sight Sciences to Present at Citi’s 2025 Unplugged MedTech and Life Sciences Access Day
February 14, 2025
·
2 min read
Press Releases
Sight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025
February 19, 2025
·
2 min read
Press Releases
Sight Sciences to Present Comprehensive Clinical Data on the OMNI® Surgical System at the 2025 American Glaucoma Society Annual Meeting
February 24, 2025
·
10 min read
Biotech Bay
Sight Sciences Announces the Release of its First Sustainability Report
Sight Sciences, Inc., an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced that it has published its first Sustainability Report, highlighting the Company’s sustainability activities, performance, and results from the last three years.
June 10, 2024
·
4 min read
Press Releases
Bionic Sight’s BS01 Gene Therapy Receives RMAT Designation from the FDA
February 18, 2025
·
3 min read
Business
Sight Sciences to Report First Quarter Financial Results on May 2, 2024
Sight Sciences, Inc. announced it will report financial results for the first quarter ended March 31, 2024, after the market close on Thursday, May 2, 2024.
April 18, 2024
·
2 min read
Business
Sight Sciences Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Financial Guidance
Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today reported financial results for the first quarter ended March 31, 2024, and reaffirmed financial guidance for full year 2024.
May 2, 2024
·
17 min read
Biotech Bay
Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference
Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today announced it will present at the upcoming 23rd Annual Needham Healthcare Conference being held virtually.
March 26, 2024
·
2 min read
Bankruptcy
Biopharma Bankruptcies Still At Peak, With Little Relief in Sight
2023 marked the most bankruptcies in biopharma in more than a decade, with 14 companies filing for Chapter 11 protection. The number remained high in 2024.
February 19, 2025
·
5 min read
·
Annalee Armstrong
Biotech Bay
Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate, and Advanced Glaucoma
Sight Sciences, Inc. announced the results as published in the journal Clinical Ophthalmology of a new analysis of the ROMEO study data.
May 28, 2024
·
7 min read
1 of 71,617
Next
